Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench-Reference-Cited by-同舟云学术

Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench

Published:2019-06-25 Issue:6 Volume:70 Page:1958-1971
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rodriguez Walter E.¹²³,Wahlang Banrida¹²³,Wang Yali¹²³,Zhang Jingwen¹²³,Vadhanam Manicka V.¹²³,Joshi‐Barve Swati¹²³⁴,Bauer Philip⁵⁶,Cannon Robert⁷^ORCID,Ahmadi Ali Reza⁸,Sun Zhaoli⁸,Cameron Andrew⁸,Barve Shirish¹²³⁴,Maldonado Claudio⁵⁶,McClain Craig¹²³⁴⁹,Gobejishvili Leila¹²³⁴

Affiliation:

1. University of Louisville Alcohol Research Center University of Louisville Louisville KY

2. Hepatobiology and Toxicology Center University of Louisville Louisville KY

3. Department of Medicine, School of Medicine University of Louisville Louisville KY

4. Department of Pharmacology and Toxicology, School of Medicine University of Louisville Louisville KY

5. Department of Physiology, School of Medicine University of Louisville Louisville KY

6. EndoProtech, Inc. Louisville KY

7. Department of Surgery, School of Medicine University of Louisville Louisville KY

8. Department of Surgery and Transplant Biology Research Center Johns Hopkins University School of Medicine Baltimore MD

9. Robley Rex VA Medical Center Louisville KY

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30761

Reference47 articles.

1. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

2. Alcoholic liver disease: mechanisms of injury and targeted treatment

3. Role of TNF-? in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury

4. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice

5. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases;Hepatology;2024-07-01

2. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26

3. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19

4. Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology;Life Sciences;2024-05

5. Hepatocyte-specific mitogen-activated protein kinase phosphatase 1 in sexual dimorphism and susceptibility to alcohol induced liver injury;Frontiers in Immunology;2024-02-01